Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis

Visceral leishmaniasis is a vector-borne protozoan infection that is fatal if untreated. There is no vaccination against the disease, and the current chemotherapeutic agents are ineffective due to increased resistance and severe side effects. Buparvaquone is a potential drug against the leishmaniase...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa, Rinez, Mondal, Subhasish, Riikonen, Joakim, Rantanen, Jimi, Näkki, Simo, Nissinen, Tuomo, Närvänen, Ale, Lehto, Vesa-Pekka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274846/
https://www.ncbi.nlm.nih.gov/pubmed/34185780
http://dx.doi.org/10.1371/journal.pntd.0009533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274846/
https://www.ncbi.nlm.nih.gov/pubmed/34185780
http://dx.doi.org/10.1371/journal.pntd.0009533

Ejemplares similares